These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28787710)

  • 1. Early Visible Improvements during K101-03 Treatment: An Open-Label Multicenter Clinical Investigation in Patients with Onychomycosis and/or Nail Psoriasis.
    Piraccini BM; Starace M; Toft A
    Dermatology; 2017; 233(2-3):178-183. PubMed ID: 28787710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of distal subungual onychomycosis with a topical preparation of urea, propylene glycol and lactic acid: results of a 24-week, double-blind, placebo-controlled study.
    Emtestam L; Kaaman T; Rensfeldt K
    Mycoses; 2012 Nov; 55(6):532-40. PubMed ID: 22681227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study.
    Lahfa M; Bulai-Livideanu C; Baran R; Ortonne JP; Richert B; Tosti A; Piraccini BM; Szepietowski JC; Sibaud V; Coubetergues H; Voisard JJ; Paul C
    Dermatology; 2013; 226(1):5-12. PubMed ID: 23467055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Retrospective Study Comparing K101 Nail Solution as a Monotherapy and in Combination with Oral Terbinafine or Itraconazole for the Treatment of Toenail Onychomycosis.
    Shemer A; Gupta AK; Babaev M; Barzilai A; Farhi R; Daniel Iii CR
    Skin Appendage Disord; 2018 Aug; 4(3):166-170. PubMed ID: 30197895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overall Prevalence and Prevalence Compared among Psoriasis Treatments of Onychomycosis in Patients with Nail Psoriasis and Fungal Involvement.
    Chularojanamontri L; Pattanaprichakul P; Leeyaphan C; Suphatsathienkul P; Wongdama S; Bunyaratavej S
    Biomed Res Int; 2021; 2021():9113418. PubMed ID: 34938812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of ustekinumab in nail psoriasis and improvement in nail-associated quality of life in a population treated with ustekinumab for cutaneous psoriasis: an open prospective unblinded study.
    Rigopoulos D; Gregoriou S; Makris M; Ioannides D
    Dermatology; 2011; 223(4):325-9. PubMed ID: 22134046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of K101 Nail Solution on Trichophyton rubrum and Candida albicans growth and ultrastructure.
    Hultenby K; Chryssanthou E; Klingspor L; Rensfeldt K; Strömbeck L; Faergemann J
    Mycoses; 2014 Oct; 57(10):630-8. PubMed ID: 24934317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onychomycosis in patients of nail psoriasis on biologic therapy: a randomized, prospective open label study comparing Etanercept, Infliximab and Adalimumab.
    Al-Mutairi N; Nour T; Al-Rqobah D
    Expert Opin Biol Ther; 2013 May; 13(5):625-9. PubMed ID: 23527597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, open-label study of the efficacy and safety of ciclopirox nail lacquer solution 8% for the treatment of onychomycosis in patients with diabetes.
    Seebacher C; Nietsch KH; Ulbricht HM
    Cutis; 2001 Aug; 68(2 Suppl):17-22. PubMed ID: 11665724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Presence of an Air Gap Between the Nail Plate and Nail Bed in Onychomycosis Patients: Treatment Implications for Topical Therapy.
    Gupta AK; Pillai R
    J Drugs Dermatol; 2015 Aug; 14(8):859-63. PubMed ID: 26267730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tazarotene as alternative topical treatment for onychomycosis.
    Campione E; Paternò EJ; Costanza G; Diluvio L; Carboni I; Marino D; Favalli C; Chimenti S; Bianchi L; Orlandi A
    Drug Des Devel Ther; 2015; 9():879-86. PubMed ID: 25733808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dystrophic psoriatic fingernails treated with 1% 5-fluorouracil in a nail penetration-enhancing vehicle: a double-blind study.
    de Jong EM; Menke HE; van Praag MC; van De Kerkhof PC
    Dermatology; 1999; 199(4):313-8. PubMed ID: 10640840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onychomycosis in psoriatic patients - rationalization of systemic treatment.
    Shemer A; Trau H; Davidovici B; Grunwald MH; Amichai B
    Mycoses; 2010 Jul; 53(4):340-3. PubMed ID: 19496936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,064-nm diode laser therapy of onychomycosis: results of a prospective open treatment of 82 toenails.
    Renner R; Grüsser K; Sticherling M
    Dermatology; 2015; 230(2):128-34. PubMed ID: 25662740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of cosmetic nail varnish does not affect the antifungal efficacy of amorolfine 5% nail lacquer in the treatment of distal subungual toenail onychomycosis: results of a randomised active-controlled study and in vitro assays.
    Sigurgeirsson B; Ghannoum MA; Osman-Ponchet H; Kerrouche N; Sidou F
    Mycoses; 2016 May; 59(5):319-26. PubMed ID: 26867498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis.
    Schaller M; Sigurgeirsson B; Sarkany M
    Mycoses; 2017 Dec; 60(12):800-807. PubMed ID: 28925059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoronychomycosis: A New Term for an Old Problem.
    Vender R; Vender R
    J Cutan Med Surg; 2016 May; 20(3):279-80. PubMed ID: 26992422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting onychomycosis in patients with psoriasis.
    Bozdemir NY; Yuksel EI; Toraman ZA; Cicek D; Demir B; Gunbey F
    Dermatol Ther; 2022 Jul; 35(7):e15513. PubMed ID: 35426221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The OnyCOE-t questionnaire: responsiveness and clinical meaningfulness of a patient-reported outcomes questionnaire for toenail onychomycosis.
    Potter LP; Mathias SD; Raut M; Kianifard F; Tavakkol A
    Health Qual Life Outcomes; 2006 Aug; 4():50. PubMed ID: 16911778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.
    Tavakkol A; Fellman S; Kianifard F
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):1-13. PubMed ID: 16730616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.